Concordantly with our findings, in human breast cancer TGFβ has an important role on tumor microenvironment switch, promoting increased angiogenic activity and suppressed immune surveillance, contributing to tumor development, progression and poor clinical outcome (Donovan et al. The gene discussed is TGFB1; the disease is neoplasm.